Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 studyEzra E.W. Cohen, Signe Friesland, Denis Soulières et al.|The Lancet|2018Cited by 1.7k
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trialSun Young Rha, Xiaochun Zhang, Marcelo Garrido et al.|The Lancet Oncology|2023Cited by 614
Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatinUlrich‐Axel Bommer, Morteza Aghmesheh|Cell Communication and Signaling|2017Cited by 50
Approach to Multiple Pulmonary Nodules: A Case Report and Review of LiteratureFarshid Niknam, Morteza Aghmesheh|The Scientific World JOURNAL|2011Cited by 2